These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30678190)

  • 1. Vasoprotective Functions of High-Density Lipoproteins Relevant to Alzheimer's Disease Are Partially Conserved in Apolipoprotein B-Depleted Plasma.
    Button EB; Gilmour M; Cheema HK; Martin EM; Agbay A; Robert J; Wellington CL
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice.
    Button EB; Boyce GK; Wilkinson A; Stukas S; Hayat A; Fan J; Wadsworth BJ; Robert J; Martens KM; Wellington CL
    Alzheimers Res Ther; 2019 May; 11(1):44. PubMed ID: 31084613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-density lipoproteins suppress Aβ-induced PBMC adhesion to human endothelial cells in bioengineered vessels and in monoculture.
    Robert J; Button EB; Stukas S; Boyce GK; Gibbs E; Cowan CM; Gilmour M; Cheng WH; Soo SK; Yuen B; Bahrabadi A; Kang K; Kulic I; Francis G; Cashman N; Wellington CL
    Mol Neurodegener; 2017 Aug; 12(1):60. PubMed ID: 28830501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrovascular amyloid Angiopathy in bioengineered vessels is reduced by high-density lipoprotein particles enriched in Apolipoprotein E.
    Robert J; Button EB; Martin EM; McAlary L; Gidden Z; Gilmour M; Boyce G; Caffrey TM; Agbay A; Clark A; Silverman JM; Cashman NR; Wellington CL
    Mol Neurodegener; 2020 Mar; 15(1):23. PubMed ID: 32213187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDL from an Alzheimer's disease perspective.
    Button EB; Robert J; Caffrey TM; Fan J; Zhao W; Wellington CL
    Curr Opin Lipidol; 2019 Jun; 30(3):224-234. PubMed ID: 30946049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clearance of beta-amyloid is facilitated by apolipoprotein E and circulating high-density lipoproteins in bioengineered human vessels.
    Robert J; Button EB; Yuen B; Gilmour M; Kang K; Bahrabadi A; Stukas S; Zhao W; Kulic I; Wellington CL
    Elife; 2017 Oct; 6():. PubMed ID: 28994390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible link between lipid metabolism and cerebral amyloid angiopathy in Alzheimer's disease: A role for high-density lipoproteins?
    Mulder M; Terwel D
    Haemostasis; 1998; 28(3-4):174-94. PubMed ID: 10420065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral administration of human recombinant ApoJ/clusterin modulates brain beta-amyloid levels in APP23 mice.
    de Retana SF; Marazuela P; Solé M; Colell G; Bonaterra A; Sánchez-Quesada JL; Montaner J; Maspoch D; Cano-Sarabia M; Hernández-Guillamon M
    Alzheimers Res Ther; 2019 May; 11(1):42. PubMed ID: 31077261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial Mitochondrial Dysfunction in Cerebral Amyloid Angiopathy and Alzheimer's Disease.
    Parodi-Rullán R; Sone JY; Fossati S
    J Alzheimers Dis; 2019; 72(4):1019-1039. PubMed ID: 31306129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pin1, endothelial nitric oxide synthase, and amyloid-β form a feedback signaling loop involved in the pathogenesis of Alzheimer's disease, hypertension, and cerebral amyloid angiopathy.
    Wang JZ; Zhu WD; Xu ZX; Du WT; Zhang HY; Sun XW; Wang XH
    Med Hypotheses; 2014 Feb; 82(2):145-50. PubMed ID: 24332564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reconstituted high-density lipoproteins acutely reduce soluble brain Aβ levels in symptomatic APP/PS1 mice.
    Robert J; Stukas S; Button E; Cheng WH; Lee M; Fan J; Wilkinson A; Kulic I; Wright SD; Wellington CL
    Biochim Biophys Acta; 2016 May; 1862(5):1027-36. PubMed ID: 26454209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity.
    de Jager M; Drukarch B; Hofstee M; Brevé J; Jongenelen CA; Bol JG; Wilhelmus MM
    J Neurochem; 2015 Sep; 134(6):1116-28. PubMed ID: 26088696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-talk between Aβ and endothelial SSAO/VAP-1 accelerates vascular damage and Aβ aggregation related to CAA-AD.
    Solé M; Miñano-Molina AJ; Unzeta M
    Neurobiol Aging; 2015 Feb; 36(2):762-75. PubMed ID: 25457560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's amyloid β heterogeneous species differentially affect brain endothelial cell viability, blood-brain barrier integrity, and angiogenesis.
    Parodi-Rullán R; Ghiso J; Cabrera E; Rostagno A; Fossati S
    Aging Cell; 2020 Nov; 19(11):e13258. PubMed ID: 33155752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial loss of endothelial nitric oxide leads to increased cerebrovascular beta amyloid.
    Austin SA; Katusic ZS
    J Cereb Blood Flow Metab; 2020 Feb; 40(2):392-403. PubMed ID: 30614363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-density lipoproteins and cerebrovascular integrity in Alzheimer's disease.
    Stukas S; Robert J; Wellington CL
    Cell Metab; 2014 Apr; 19(4):574-91. PubMed ID: 24508505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reassembly of native components with donepezil to execute dual-missions in Alzheimer's disease therapy.
    Zhang H; Zhao Y; Yu M; Zhao Z; Liu P; Cheng H; Ji Y; Jin Y; Sun B; Zhou J; Ding Y
    J Control Release; 2019 Feb; 296():14-28. PubMed ID: 30639387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal high-fat diet alters the cerebrovasculature and clearance of β-amyloid in adult offspring.
    Hawkes CA; Gentleman SM; Nicoll JA; Carare RO
    J Pathol; 2015 Mar; 235(4):619-31. PubMed ID: 25345857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Traffic jam at the blood-brain barrier promotes greater accumulation of Alzheimer's disease amyloid-β proteins in the cerebral vasculature.
    Agyare EK; Leonard SR; Curran GL; Yu CC; Lowe VJ; Paravastu AK; Poduslo JF; Kandimalla KK
    Mol Pharm; 2013 May; 10(5):1557-65. PubMed ID: 23249146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomimetic ApoE-Reconstituted High Density Lipoprotein Nanocarrier for Blood-Brain Barrier Penetration and Amyloid Beta-Targeting Drug Delivery.
    Song Q; Song H; Xu J; Huang J; Hu M; Gu X; Chen J; Zheng G; Chen H; Gao X
    Mol Pharm; 2016 Nov; 13(11):3976-3987. PubMed ID: 27700119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.